Related Experiment Video
Updated: May 5, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Carotid Artery Stenting: Evolution, Evidence, and Contemporary Practice in the Era of Intensive Medical Therapy
Sakshi Dixit1, Fnu Anamika1, Anmol Multani2
1Cleveland Clinic Akron General, Akron, OH 44307, USA.
Insights
Carotid artery stenting (CAS) and carotid endarterectomy (CEA) offer comparable outcomes for stroke prevention. Optimal treatment involves individualized decisions balancing procedural risks, benefits, and intensive medical therapy for long-term vascular health.
Area of Science:
- Vascular Surgery
- Neurology
- Interventional Cardiology
Background:
- Carotid artery stenosis is a leading cause of ischemic stroke globally.
- Carotid endarterectomy (CEA) is the standard for symptomatic high-grade stenosis.
- Carotid artery stenting (CAS) offers a less invasive alternative for select patients.
Purpose of the Study:
- To review the historical development of CAS.
- To compare evidence from major clinical trials of CAS versus CEA.
- To examine current practices in the context of advanced medical therapies.
Main Methods:
- Comprehensive review of randomized trials, registries, and guidelines.
- Synthesis of evidence on procedural outcomes and patient selection.
- Inclusion of emerging technologies like transcarotid artery revascularization (TCAR).
Main Results:
- CAS and CEA demonstrate similar long-term composite outcomes in selected patients.
- CAS carries a higher peri-procedural stroke risk; CEA has higher myocardial infarction rates.
- Advances in embolic protection and stent technology enhance endovascular approaches.
Conclusions:
- Intensive medical therapy significantly reduces stroke risk, especially in asymptomatic individuals.
- Optimal stroke prevention requires personalized, multidisciplinary decision-making.
- Management integrates symptom status, anatomy, comorbidities, expertise, and risk factor control.
Abstract:
Carotid artery stenosis remains a major cause of ischemic stroke worldwide, and its management continues to evolve in parallel with advances in surgical, endovascular, and medical therapies. Carotid endarterectomy (CEA) was established as the standard of care for symptomatic high-grade stenosis following landmark randomized trials, while carotid artery stenting (CAS) subsequently emerged as a less invasive alternative for appropriately selected patients. This review aims to summarize the historical evolution of carotid artery stenting, critically appraise evidence from major clinical trials comparing CAS and CEA, and examine contemporary practice patterns in the era of intensive medical therapy. A comprehensive review of randomized trials, registries, guideline statements, and recent literature was performed to synthesize current evidence regarding procedural outcomes, patient selection, and emerging technologies, including transcarotid artery revascularization (TCAR). Large, randomized trials have demonstrated comparable long-term composite outcomes between CAS and CEA in selected patients, although peri-procedural risk profiles differ, with higher stroke risk observed after CAS and higher myocardial infarction rates after CEA. Technological advancements in embolic protection devices, stent platforms, and alternative access strategies have further refined endovascular approaches. Concurrently, improvements in intensive medical therapy-including lipid-lowering, antiplatelet therapy, blood pressure control, smoking cessation, and lifestyle modification-have substantially reduced overall stroke risk, particularly in asymptomatic patients. In the contemporary era, optimal stroke prevention requires individualized, multidisciplinary decision-making that integrates symptom status, anatomical complexity, comorbid conditions, procedural expertise, and sustained long-term vascular risk factor management following revascularization.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management
Acute Coronary Syndrome I: Introduction
Peripheral Artery Disease III: Interprofessional Care

